Latest Insider Transactions at Galectin Therapeutics Inc (GALT)
This section provides a real-time view of insider transactions for Galectin Therapeutics Inc (GALT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GALECTIN THERAPEUTICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GALECTIN THERAPEUTICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,296
+1.61%
|
$12,888
$3.88 P/Share
|
|
Sep 23
2021
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
3,000
+8.33%
|
$9,000
$3.88 P/Share
|
|
Sep 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,468
+1.71%
|
$13,404
$3.73 P/Share
|
|
Sep 01
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$30,000
$3.91 P/Share
|
|
Aug 31
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,241
+1.65%
|
$12,723
$3.93 P/Share
|
|
Aug 13
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,931
+1.94%
|
$14,793
$3.38 P/Share
|
|
Aug 02
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$30,000
$3.25 P/Share
|
|
Jul 30
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,061
+2.43%
|
$12,122
$2.75 P/Share
|
|
Jul 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,435
+2.63%
|
$12,870
$2.59 P/Share
|
|
Jul 09
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$30,000
$3.54 P/Share
|
|
Jun 30
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,208
+2.2%
|
$15,624
$3.2 P/Share
|
|
Jun 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,762
+2.06%
|
$14,286
$3.5 P/Share
|
|
Jun 01
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$30,000
$3.91 P/Share
|
|
Jun 01
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,198
+1.86%
|
$12,594
$3.97 P/Share
|
|
May 14
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,940
+1.78%
|
$15,760
$4.23 P/Share
|
|
May 03
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$30,000
$3.84 P/Share
|
|
Apr 30
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,771
+1.74%
|
$15,084
$4.42 P/Share
|
|
Apr 26
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,500
-0.12%
|
$30,000
$4.47 P/Share
|
|
Apr 23
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$15,000
$3.95 P/Share
|
|
Apr 22
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$15,000
$3.52 P/Share
|
|
Apr 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,474
+3.45%
|
$14,948
$2.23 P/Share
|
|
Apr 05
2021
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
5,000
+14.29%
|
$10,000
$2.04 P/Share
|
|
Apr 01
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$20,000
$2.16 P/Share
|
|
Mar 31
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,680
+3.66%
|
$15,360
$2.17 P/Share
|
|
Mar 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,667
+3.32%
|
$13,334
$2.5 P/Share
|
|
Mar 05
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
27,027
+11.18%
|
$54,054
$2.22 P/Share
|
|
Mar 01
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$20,000
$2.31 P/Share
|
|
Feb 26
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,440
+3.81%
|
$14,880
$2.24 P/Share
|
|
Feb 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,693
+3.58%
|
$13,386
$2.49 P/Share
|
|
Feb 02
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$20,000
$2.04 P/Share
|
|
Jan 29
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,503
+4.67%
|
$8,503
$1.96 P/Share
|
|
Jan 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,610
+4.41%
|
$15,220
$2.19 P/Share
|
|
Jan 11
2021
|
Gilbert F Amelio |
SELL
Open market or private sale
|
Direct |
60,000
-49.75%
|
$120,000
$2.17 P/Share
|
|
Jan 04
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$20,000
$2.23 P/Share
|
|
Dec 31
2020
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,440
+4.51%
|
$14,880
$2.24 P/Share
|
|
Dec 15
2020
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,614
+4.22%
|
$13,228
$2.52 P/Share
|
|
Nov 30
2020
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,410
+4.28%
|
$12,820
$2.6 P/Share
|
|
Nov 13
2020
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,061
+4.24%
|
$12,122
$2.75 P/Share
|
|
Oct 30
2020
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,562
+4.77%
|
$13,124
$2.54 P/Share
|
|
Oct 15
2020
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,807
+4.46%
|
$11,614
$2.87 P/Share
|
|
Oct 13
2020
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$20,000
$2.97 P/Share
|
|
Sep 30
2020
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,242
+5.0%
|
$12,484
$2.67 P/Share
|